A conditional mouse model of malignant pleural mesothelioma

Anthi Krontira (Patras, Greece), Anthi Krontira, Malamati Vreka, Marianthi Iliopoulou, Ioannis Lilis, Theodora Agalioti, Nicoleta Spiropoulou, Georgia Giotopoulou, Yuval Rinkevich, Magda Spella, Georgios Stathopoulos, Antonia Marazioti

Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside

Session: Mesothelioma and pleural disease: from the bench to the bedside
Session type: Oral Presentation
Number: 497

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Anthi Krontira (Patras, Greece), Anthi Krontira, Malamati Vreka, Marianthi Iliopoulou, Ioannis Lilis, Theodora Agalioti, Nicoleta Spiropoulou, Georgia Giotopoulou, Yuval Rinkevich, Magda Spella, Georgios Stathopoulos, Antonia Marazioti. A conditional mouse model of malignant pleural mesothelioma. Eur Respir J 2016; 48: Suppl. 60, 497

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Management of malignant pleural mesothelioma Source: ERS Skills Course 2015 Year: 2015
Management of malignant pleural mesothelioma Source: ERS Course 2016 - Skills course on medical thoracoscopy Year: 2016
Management of malignant pleural mesothelioma Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013
Management of malignant pleural mesothelioma Source: Hands-on Course 2012 - Medical Thoracoscopy Year: 2012
Management of malignant pleural mesothelioma Source: School Course 2014 - Medical Thoracoscopy Year: 2014
Role of tumor derived versican in experimental malignant pleural mesothelioma Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016
Effect of smoking on experimental malignant pleural effusion Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015
Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
Management of malignant mesothelioma Source: ERS Skills Course 2018 - Practical Pleural Skills Year: 2018
Pleural mesothelioma with solitary simultaneous subcutaneous tissue metastasis of the abdominal wall at diagnosis - First clinical documentation Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013
Diagnosis of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 527s Year: 2004
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: In-vitro study Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015
Volume quantification of malignant pleural mesothelioma Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015
Biochemical parameters in malignant pleural mesothelioma and pulmonary adenocarcinoma Source: Eur Respir J 2005; 26: Suppl. 49, 74s Year: 2005
Management of malignant pleural mesothelioma in 2017 Source: ERS Skills course - Medical thoracoscopy Year: 2017
Tumours of the pleura - Mesothelioma Source: Respipedia Article Year: 2017
A conditional contribution of mast cells to malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013
Diagnosis and staging of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020